Analysts expect over 2020 rising revenue Merck KGaA

Tomorrow the German Merck KGaA KGaA will publish its past quarter figures. Over the current book year the total revenue will be 16,09 billion euros (consensus estimates). This is slightly more than 2018's revenue of 14,84 billion euros.

Historical revenues and results Merck KGaA KGaA plus estimates 2020

fundamental research

The analysts expect for 2020 a net profit of 2,4 billion euros. According to most of the analysts the company will have a profit per share for this book year of 5,56 euros. Based on this the price/earnings-ratio is 20,35.

Per share the analysts expect a dividend of 1,3 euros per share. Thus the dividend yield equals 1,15 percent. The average dividend yield of the pharmaceutical companies is an attractive 5,87260073067741 percent.

Most recent target prices around 117 euros

The latest 3 recommendations for the pharmaceutical company were provided by Deutsche Bank, Credit Suisse and JP Morgan.

Merck KGaA KGaA's market capitalization is based on the number of outstanding shares around 14,62 billion euros. The Merck KGaA KGaA stock was the past 12 months quite volatile. Since last March the stock is even 23 percent higher. This year the stock price moved between 86 and 126 euro. Since 2008 the stock price is almost 272 percent higher.

Price data Merck KGaA KGaA 2007-2020

fundamental research merckkgaa

Click here for dividend . At 13.19 the stock trades 1,37 percent higher at 113,15 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.